Histological impact of medical therapy--clinical implications
RCT
OA: closed
CC0
⤵ 8 in-corpus citations
AI-generated summary
This study observed that both danazol and gestrinone caused endometrial atrophy in endometriosis patients, with danazol inducing more rapid and severe changes after 6 months of treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The medium- and long-term effects of gestrinone and danazol on the endometrium were examined in 36 patients with endometriosis. Endometrial biopsies were taken from each patient before treatment and after 3 and 6 months of treatment with 600 mg danazol daily (n = 17) or with 2.5 mg gestrinone twice weekly (n = 19). Endometrial samples were analysed by light, scanning and transmission electron microscopy. At 3 months' treatment the endometria of patients treated with danazol appeared more atrophic than those of the women treated with gestrinone; some cell organelle involution was evident in all patients. After 6 months of treatment a marked atrophy was observed in patients of both treatment groups. A complete involution of cytoplasmic organelles with cytoplasmic collapse and a shift of nucleoplasmic ratio in favour of the nucleus occurred in patients treated with danazol; the cytoplasmic organelle involution was less marked in patients treated with gestrinone. Compared with gestrinone, danazol induces more rapid endometrial atrophy, with greater impairment of the cytoplasm and cell secretory activity.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (8)
- Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study via openalex
- Endometrial patterns during danazol and cyproterone acetate treatment for endometriosis: structural and ultrastructural study via openalex
- Endometrial patterns during therapy with danazol or gestrinone for endometriosis: structural and ultrastructural study via openalex
- Morphology of endometriosis before and during treatment with danazol via openalex
- Short-term effects of danazol on endometrial histology via openalex
- W2477008945 via openalex
- W2051145289 via openalex
- W66902808 via openalex
Cited by (7)
- Progestagens for pain symptoms associated with endometriosis 2025
- Evaluation of safety and effectiveness of gestrinone in the treatment of endometriosis: a systematic review and meta-analysis 2022
- Progestagens and anti-progestagens for pain associated with endometriosis 2012
- Current pharmacotherapy for endometriosis 2010
- [Medical treatment of idiopathic menorrhagia] 2008
- Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation 2006
- Progestagens and anti-progestagens for pain associated with endometriosis 2000
Source provenance
- europepmc
- last seen: 2026-10-09T06:09:53.026058+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:58:54.395363+00:00
- unpaywall
- last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0
· commercial use OK